Browsing byAuthor유대현

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 75 to 94 of 112

Issue DateTitleAuthor(s)
2020-11A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis유대현
2013-06A PHASE 3 RANDOMISED CONTROLLED TRIAL TO COMPARE CT-P13 WITH INFLIXIMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 54 WEEK RESULTS FROM THE PLANETRA STUDY유대현
2016-04A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study유대현
2013-06PILOT TRIAL OF TOCILIZUMAB FOR REFRACTORY PATIENTS WITH ADULT ONSET STILL'S DISEASE유대현
2013-06PREDICTOR OF RENAL SURVIVAL IN LUPUS NEPHRITIS IN KOREA유대현
2016-09Prevalence and possible causes of hypouricemia at a tertiary care hospital유대현
2019-04Prevalence and predictors for sustained remission in rheumatoid arthritis유대현
2013-06PREVALENCE AND PREDICTORS FOR SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS유대현
2013-06PREVALENCE AND PREDICTORS FOR SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS유대현
2018-07Prevalence of co-morbidities and evaluation of their monitoring in Korean patients with rheumatoid arthritis: comparison with the results of an international, cross-sectional study (COMORA)유대현
2013-10Quality Of Life In Rheumatoid Arthritis: Cross-National Comparison Study Between US and South Korea유대현
2013-10A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study유대현
2013-10A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study유대현
2013-06A RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 1 STUDY COMPARING THE PHARMACOKINETICS, SAFETY AND EFFICACY OF CT-P13 AND INFLIXIMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 54 WEEK RESULTS FROM THE PLANETAS STUDY유대현
2013-07The relationship between peripheral arthritis and anti-cyclic citrullinated peptide antibodies in ankylosing spondylitis유대현
2015-11Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-alpha treatment and comparison to other guidelines유대현
2014-08The rise of biosimilars: potential benefits and drawbacks in rheumatoid arthritis유대현
2014-06THE RISK FACTORS FOR NONADHERENCE TO ANTI-RHEUMATIC TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS유대현
2020-01Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trials유대현
2020-01Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity유대현

BROWSE